PET/CT combines functional and anatomical imaging to provide information about biological activity alongside detailed structural information. By using specialized radiopharmaceuticals, PET/CT can help physicians evaluate specific biological processes and support the assessment of a range of clinical conditions.
At Tawam Molecular Imaging Centre (TMIC), PET/CT imaging is supported by specialized radiopharmaceuticals, advanced imaging technology, and an integrated molecular imaging infrastructure. The appropriate examination and radiopharmaceutical are selected according to the patient’s clinical history, the suspected condition, and the clinical question being investigated. PET/CT may be used across a range of clinical areas, with examinations tailored to the specific diagnostic or clinical question.
In oncology, PET/CT can provide valuable information at different stages of cancer care. Depending on the type of cancer, radiopharmaceutical used, and clinical question, it helps physicians assess the extent of disease, support cancer staging, evaluate treatment response, investigate suspected recurrent or persistent disease, and provide information that may contribute to treatment planning.
At Tawam Molecular Imaging Centre (TMIC), specialized radiopharmaceuticals and PET/CT imaging support a range of oncology applications, with the appropriate examination selected according to the patient’s clinical indication.
page absolute URL Learn MoreCardiac PET/CT is an advanced molecular imaging technique used to assess physiological processes within the heart, including myocardial blood flow, perfusion, metabolism, and other cardiac functions. Depending on the radiopharmaceutical and examination performed, cardiac PET/CT can provide information that helps physicians evaluate how well blood is reaching the heart muscle, assess myocardial viability, and investigate selected inflammatory and other cardiac conditions.
At Tawam Molecular Imaging Centre (TMIC), specialized cardiac PET/CT imaging supports the assessment of patients with suspected or known coronary artery disease and other cardiac conditions where molecular imaging may provide clinically relevant information.
page absolute URL Learn MoreWhen it comes to evaluating neurological conditions, having the right information can help physicians make more informed clinical decisions. Neurological disorders can affect the brain, spinal cord, and nervous system, influencing functions such as cognition, movement, and sensation. PET/CT adds another dimension to neurological imaging by providing information about metabolic and molecular activity that may not be visible through structural imaging alone. By combining PET with CT, the examination provides functional information alongside detailed anatomical imaging, helping physicians evaluate specific neurological conditions and clinical questions. Molecular imaging can complement structural imaging such as MRI and CT by providing insight into biological processes within the brain. Depending on the radiopharmaceutical used, PET can demonstrate patterns of metabolism or specific molecular activity that may support the evaluation of selected neurological conditions.
page absolute URL Learn MoreAt Tawam Molecular Imaging Centre (TMIC), advanced molecular imaging is supported by an integrated on-site cyclotron and radiopharmacy facility. By bringing radionuclide production, radiopharmaceutical preparation, quality control, and PET/CT imaging together within the same centre, TMIC connects the essential stages of the molecular imaging pathway in one coordinated environment. This integrated capability supports the availability and preparation of specialized radiopharmaceuticals for applications across oncology, cardiology, and neurology. It combines advanced technology, specialized infrastructure, quality-control systems, and professional expertise to support the delivery of sophisticated PET/CT imaging services.
page absolute URL Learn More